Phase I study of vorinostat in combination with isotretinoin in patients with refractory/recurrent neuroblastoma: A new approaches to Neuroblastoma Therapy (NANT) trial
Journal article published in 2018 by
Navin Pinto 
,
Steven G. DuBois ,
Araz Marachelian,
Scott J. Diede ,
Agne Taraseviciute,
Julia L. Glade Bender,
Denice Tsao-Wei,
Susan G. Groshen,
Joel M. Reid,
Daphne A. Haas-Kogan,
C. Patrick Reynolds,
Min H. Kang,
Meredith S. Irwin ,
Margaret E. Macy ,
Judith G. Villablanca
and other authors.
,
Steven G. DuBois ,
Araz Marachelian,
Scott J. Diede ,
Agne Taraseviciute,
Julia L. Glade Bender,
Denice Tsao-Wei,
Susan G. Groshen,
Joel M. Reid,
Daphne A. Haas-Kogan,
C. Patrick Reynolds,
Min H. Kang,
Meredith S. Irwin ,
Margaret E. Macy ,
Judith G. Villablanca
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 